Charles Ibeakanma1, Stephen Vanner. 1. Gastrointestinal Diseases Research Unit, Kingston General Hospital, 76 Stuart Street, Kingston, Ontario, Canada.
Abstract
OBJECTIVES: Abdominal pain is a serious cause of morbidity in patients with inflammatory bowel disease. To better understand the mechanisms and potentially identify new targets for treatment, the effects of inflammatory supernatant from colonic biopsies of patients with active ulcerative colitis (UC) on mouse colonic nociceptive dorsal root ganglia neurons were examined. METHODS: Acutely dissociated dorsal root ganglia neurons innervating the mouse colon were incubated in supernatants obtained from colonic biopsies from patients with UC. Whole-cell patch clamp recordings were obtained to examine the effects on neuronal excitability. The role of tumour necrosis factor alpha (TNFalpha) was studied using TNFalpha receptor (TNFR) knockout mice and comparing supernatant and TNFalpha actions. RESULTS: UC supernatants significantly decreased the rheobase and increased action potential discharge, indicating increased neuronal excitability. Human biopsies exhibited high levels of TNFalpha, and mouse colonic neurons only exhibited TNFR1 mRNA. Incubation with TNFalpha recapitulated the supernatant effects on neuronal excitability, and supernatant and TNFalpha actions were almost completely blocked in TNFR knockout mice. In voltage clamp studies, transient I(A) and I(K) currents were suppressed and Na(v) 1.8 currents were enhanced by TNFalpha and UC supernatant, suggesting that multiple underlying mechanisms contributed to the enhanced excitability. CONCLUSIONS: UC supernatants enhance neuronal excitability of sensory dorsal root ganglia neurons innervating the colon. TNFalpha is a key mediator which acts at neuronal TNFR1 to modulate K(v) and Na(v) currents. Together these data provide a number of potential new targets for pain management in UC.
OBJECTIVES:Abdominal pain is a serious cause of morbidity in patients with inflammatory bowel disease. To better understand the mechanisms and potentially identify new targets for treatment, the effects of inflammatory supernatant from colonic biopsies of patients with active ulcerative colitis (UC) on mousecolonic nociceptive dorsal root ganglia neurons were examined. METHODS: Acutely dissociated dorsal root ganglia neurons innervating the mouse colon were incubated in supernatants obtained from colonic biopsies from patients with UC. Whole-cell patch clamp recordings were obtained to examine the effects on neuronal excitability. The role of tumour necrosis factor alpha (TNFalpha) was studied using TNFalpha receptor (TNFR) knockout mice and comparing supernatant and TNFalpha actions. RESULTS: UC supernatants significantly decreased the rheobase and increased action potential discharge, indicating increased neuronal excitability. Human biopsies exhibited high levels of TNFalpha, and mouse colonic neurons only exhibited TNFR1 mRNA. Incubation with TNFalpha recapitulated the supernatant effects on neuronal excitability, and supernatant and TNFalpha actions were almost completely blocked in TNFR knockout mice. In voltage clamp studies, transient I(A) and I(K) currents were suppressed and Na(v) 1.8 currents were enhanced by TNFalpha and UC supernatant, suggesting that multiple underlying mechanisms contributed to the enhanced excitability. CONCLUSIONS: UC supernatants enhance neuronal excitability of sensory dorsal root ganglia neurons innervating the colon. TNFalpha is a key mediator which acts at neuronal TNFR1 to modulate K(v) and Na(v) currents. Together these data provide a number of potential new targets for pain management in UC.
Authors: Andelain Erickson; Annemie Deiteren; Andrea M Harrington; Sonia Garcia-Caraballo; Joel Castro; Ashlee Caldwell; Luke Grundy; Stuart M Brierley Journal: J Physiol Date: 2018-02-06 Impact factor: 5.182
Authors: Raquel Guerrero-Alba; Eduardo Emmanuel Valdez-Morales; Nestor Nivardo Jiménez-Vargas; Romke Bron; Daniel Poole; David Reed; Joel Castro; Melissa Campaniello; Patrick A Hughes; Stuart M Brierley; Nigel Bunnett; Alan E Lomax; Stephen Vanner Journal: Br J Pharmacol Date: 2018-05-22 Impact factor: 8.739
Authors: Cengiz Z Altuntas; Firouz Daneshgari; Elias Veizi; Kenan Izgi; Fuat Bicer; Ahmet Ozer; Kerry O Grimberg; Bakytzhan Bakhautdin; Cagri Sakalar; Cemal Tasdemir; Vincent K Tuohy Journal: Am J Physiol Regul Integr Comp Physiol Date: 2013-01-23 Impact factor: 3.619
Authors: Javier Aguilera-Lizarraga; Morgane V Florens; Maria Francesca Viola; Piyush Jain; Lisse Decraecker; Iris Appeltans; Maria Cuende-Estevez; Naomi Fabre; Kim Van Beek; Eluisa Perna; Dafne Balemans; Nathalie Stakenborg; Stavroula Theofanous; Goele Bosmans; Stéphanie U Mondelaers; Gianluca Matteoli; Sales Ibiza Martínez; Cintya Lopez-Lopez; Josue Jaramillo-Polanco; Karel Talavera; Yeranddy A Alpizar; Thorsten B Feyerabend; Hans-Reimer Rodewald; Ricard Farre; Frank A Redegeld; Jiyeon Si; Jeroen Raes; Christine Breynaert; Rik Schrijvers; Cédric Bosteels; Bart N Lambrecht; Scott D Boyd; Ramona A Hoh; Deirdre Cabooter; Maxim Nelis; Patrick Augustijns; Sven Hendrix; Jessica Strid; Raf Bisschops; David E Reed; Stephen J Vanner; Alexandre Denadai-Souza; Mira M Wouters; Guy E Boeckxstaens Journal: Nature Date: 2021-01-13 Impact factor: 49.962
Authors: Ya-Chi Huang; Marjan S Rupnik; Negar Karimian; Pedro L Herrera; Patrick Gilon; Zhong-Ping Feng; Herbert Y Gaisano Journal: Diabetes Date: 2012-10-05 Impact factor: 9.461